The Division of Gastrointestinal Surgery, University of South Florida Morsani College of Medicine, 5 Tampa General Circle, Suite 740, Tampa, FL, 33606, USA.
Surg Endosc. 2023 Jan;37(1):255-265. doi: 10.1007/s00464-022-09463-9. Epub 2022 Aug 3.
The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the "real-world."
Google Scholar, PubMed, and Web of Science websites search was done using the keywords "GERD-HRQL" or its author, "Velanovich." Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied.
A total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact.
The GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject.
GERD-HRQL 症状严重程度量表于 25 年前开发并发布。现在回顾一下该量表在“真实世界”中的应用情况似乎很合适。
使用“GERD-HRQL”或其作者“Velanovich”等关键词在 Google Scholar、PubMed 和 Web of Science 网站上进行搜索。一旦确定了文章，就从每篇文章中获取以下信息：第一作者姓名、原籍国、发表的期刊、发表年份、研究设计类型、研究主题、研究类别、研究疾病类型、研究目的、GERD-HRQL 评分的报告方式、GERD-HRQL 评分的统计报告方式以及研究结果。根据研究疾病过程和干预措施，对总分和变化分数进行描述性统计分析。
共在 193 种不同期刊中确定了 562 位不同第一作者的 767 篇文章，研究来源国为 53 个不同国家。经过一段时间的稳定使用后，过去 5 年来，采用 GERD-HRQL 的出版物数量迅速增加。已有 8 种语言的验证翻译版本，尽管存在许多非验证的临时翻译版本。最常用或研究的是：观察性队列研究设计、手术治疗研究类别、GERD 疾病过程、治疗效果研究目的、总 GERD-HRQL 评分报告为平均值或中位数。然而，也有各种各样的其他研究设计、研究类别、疾病过程和研究目的。一般来说，GERD 和喉咽反流的治疗前评分较高（即症状更严重），手术和内镜干预的治疗后评分最低（即症状最不严重），评分变化最大（即治疗效果最显著）。
GERD-HRQL 已被证明是一种可靠、敏感和多功能的症状严重程度量表，适用于以 GERD 为研究主题的研究。
